Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer
作者:Shilei Li、Xiao Wang、Yong He、Mingxia Zhao、Yurong Chen、Jingli Xu、Man Feng、Jin Chang、Hongyu Ning、Chuanmin Qi
DOI:10.1016/j.ejmech.2013.06.055
日期:2013.9
Thirteen novel quinazoline nitrogen mustard derivatives were designed, synthesized and evaluated for their anticancer activities in vitro and in vivo. Cytotoxicity assays were carried out in five cancer cell lines (HepG2, SH-SY5Y, DU145, MCF-7 and A549) and one normal human cell line (GES-1), in which compound 22b showed very low IC50 to HepG2 (the IC50 value is 3.06 μM), which was lower than Sorafenib
设计,合成和评估了十三种新颖的喹唑啉氮芥子气衍生物在体外和体内的抗癌活性。在五种癌细胞系(HepG2,SH-SY5Y,DU145,MCF-7和A549)和一种正常人细胞系(GES-1)中进行了细胞毒性测定,其中化合物22b对HepG2的IC 50非常低( IC 50值为3.06μM),低于索拉非尼。化合物22b可以抑制S和G 2 / M期的细胞周期并诱导细胞凋亡。在HepG2异种移植模型中,22b在体内具有显着的癌生长抑制作用,且宿主毒性低。